The purpose of this study is to find a recommended dose level and schedule of dosing
LY2940680 that can safely be taken by participants with advanced cancer. The study will also
explore the changes in a cancer marker level in skin, hair follicles, buccal cells, and tumor
cells. Finally, the study will help document any antitumor activity this drug may have.